Axon Enterprise shares climbed 7.3% in morning trading as investors increased exposure ahead of the company’s Q2 2026 earnings report, which is scheduled to be released after the market closes today. Analysts are projecting quarterly revenue near $876 million and earnings per share around $1.84, setting a demanding benchmark the market currently appears to be pricing in.
The uptick in buying interest has been supported by a broadly positive analyst consensus. According to available tallies, 21 analysts carry an average Buy rating on the stock. In recent months several firms have raised their price targets, including Piper Sandler, which raised its target to $724 accompanied by an Overweight rating, and Needham, which lifted its target to $750.
Those upward revisions reflect mounting conviction among analysts that Axon’s faster-growing software and AI segments are materially reshaping the company’s revenue mix beyond its traditional TASER hardware business. Internal metrics cited by the market show AI-related revenue expanded roughly 140% in Q1, while the Dedrone counter-drone platform reportedly grew approximately 300% year-over-year in the same period. Market participants have interpreted that momentum as evidence the company’s growth profile is accelerating.
The market backdrop also contributed to the stock’s strength. The broader S&P 500 advanced 0.8% during the session and the Nasdaq Composite rose 1.0%, creating a risk-on environment that lifted sentiment across technology names and public safety technology peers. Comparing peers, Axon’s closest comparable, Motorola Solutions, has historically grown at a fraction of Axon’s pace - a differential bulls say helps justify a premium valuation multiple for Axon.
Taken together, imminent earnings anticipation, a supportive analyst consensus with rising price targets, and a constructive market tone have combined to produce today’s sharp move higher in the shares. With the Q2 report due after the close, traders are betting that continued rapid revenue growth and expansion of Axon’s AI-driven software business will translate into results that meet or beat the already-elevated forecasts.
Summary
Axon stock jumped 7.3% in morning trading as investors positioned ahead of Q2 2026 results due after the close. Analysts forecast about $876 million in revenue and $1.84 in EPS. Upgraded price targets and strong AI- and Dedrone-related growth are cited as reasons for heightened optimism, all against a risk-on market that saw the S&P 500 and Nasdaq gain ground.
Key points
- Analyst sentiment is strongly positive - 21 analysts carry an average Buy rating, with recent target increases from Piper Sandler to $724 and Needham to $750.
- Axon’s software and AI operations are growing rapidly - AI-related revenue rose roughly 140% in Q1 and the Dedrone platform grew about 300% year-over-year.
- Market conditions were favorable today, with the S&P 500 up 0.8% and the Nasdaq Composite up 1.0%, supporting gains in technology and public safety technology stocks.
Risks and uncertainties
- High expectations set by consensus forecasts - projected revenue near $876 million and EPS of about $1.84 create a high bar that could magnify market moves if results disappoint.
- Company valuation reflects a premium - bulls point to faster growth versus peers, but that premium depends on continued outperformance.
- Market sentiment could shift - today’s gains were supported by a risk-on tape; adverse market moves could weigh on the stock ahead of or after the earnings release.